Regency Capital Management
TMDX icon

Regency Capital Management’s Transmedics TMDX Stock Holding History

Regency Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4,841
Closed -$322K – 70
2026
Q2 		$322K Sell
4,841
-17,005
-78% -$1.44M 0.13% 59
2026
Q1 		$2.17M Buy
+21,846
New +$2.85M 0.97% 33

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Zevenbergen Capital Investments
Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Regency Capital Management's TMDX Position: Q3 2026 in Review

Regency Capital Management sold out of Transmedics (TMDX) in Q3 2026, closing a stake of 4,841 shares — an estimated $322K sold.

Regency Capital Management first reported a position in TMDX in Q1 2026 and held it in 2 quarters. The position peaked at $2.17M in Q1 2026. 217 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Regency Capital Management reported no remaining Transmedics position as of Q3 2026 after selling out during the quarter.
  • Regency Capital Management sold 4,841 Transmedics shares in Q3 2026, an estimated $322K.
  • Regency Capital Management first reported a position in Transmedics in Q1 2026 and held it in 2 quarters.
  • Regency Capital Management's Transmedics position peaked at $2.17M in Q1 2026.
  • 217 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Regency Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.